Phreesia, Inc. (PHR) stock
PHRNYSEServices-Business Services, NECFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 8/3031% above fair value
$12.69+0.07 (+0.55%)
Close on Nov 13, 2026Market cap $787.68MP/E 74.6Yield –
Phreesia r&d expenses
Research and development expenses are spending on new products and technology.
Phreesia's R&D Expenses for the twelve months ending Jul 31, 2026 was $116.28M, down 3.1% year over year. For fiscal 2026 it was $121.48M, up 3.5% from the year before. The highest annual figure on record is $121.48M in fiscal 2026.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $121.48M | +3.5% |
| FY2025 | Jan 31, 2025 | $117.36M | +4.5% |
| FY2024 | Jan 31, 2024 | $112.35M | +23.1% |
| FY2023 | Jan 31, 2023 | $91.24M | +74.6% |
| FY2022 | Jan 31, 2022 | $52.27M | +131.0% |
| FY2021 | Jan 31, 2021 | $22.62M | +21.5% |
| FY2020 | Jan 31, 2020 | $18.62M | +29.8% |
| FY2019 | Jan 31, 2019 | $14.35M | +26.1% |
| FY2018 | Jan 31, 2018 | $11.38M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $27.57M | -5.8% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $28.33M | -11.0% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $30.93M | +4.4% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $29.45M | +0.5% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $29.27M | -0.9% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | $31.83M | +10.2% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $29.63M | -0.8% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | $29.32M | +2.7% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | $29.54M | +7.5% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | $28.88M | +9.1% |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $29.86M | +17.6% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $28.54M | +25.9% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $27.47M | +21.9% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $26.47M | +28.3% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $25.40M | +45.2% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $22.67M | +48.4% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $22.54M | +97.0% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $20.64M | +156.2% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $17.50M | +175.3% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $15.27M | +166.5% |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | $11.44M | +106.9% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $8.05M | +60.9% |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $6.36M | +30.7% |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $5.73M | +20.1% |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $5.53M | +17.9% |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | $5.01M | +16.4% |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | $4.86M | +15.6% |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | $4.77M | +23.8% |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | $4.69M | +47.5% |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | $4.30M | – |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | $4.21M | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | $3.86M | – |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | $3.18M | – |
See a number that looks wrong?